| 新生儿糖尿病研究进展 |
| |
| 引用本文： | 刘颖,陶于洪. 新生儿糖尿病研究进展[J]. 国际儿科学杂志, 2011, 38(6): 606-608. DOI: 10.3760/cma.j.issn.1673-4408.2011.06.024 |
| |
| 作者姓名： | 刘颖 陶于洪 |
| |
| 作者单位： | 四川大学华西第二医院儿科,成都,610041 |
| |
| 摘 要： | 新生儿糖尿病是一组异质性单基因遗传病,常被误诊为1型糖尿病.永久性新生儿糖尿病与免疫无关,主要与KCNJ 11、ABCC8和胰岛素基因等基因突变有关；多以酮症酸中毒起病,伴宫内发育迟缓、脱水.基因检测有助于疾病分型,并可根据不同致病基因进行靶向治疗.对于ATP敏感的K+通道基因突变的永久性新生儿糖尿病患儿可口服磺脲类降...
|
| 关 键 词： | 新生儿糖尿病 基因突变 治疗 |
Progress of neonatal diabetes mellitus |
| |
| LiU Ying,TAO Yu-hong. Progress of neonatal diabetes mellitus[J]. International Journal of Pediatrics, 2011, 38(6): 606-608. DOI: 10.3760/cma.j.issn.1673-4408.2011.06.024 |
| |
| Authors: | LiU Ying TAO Yu-hong |
| |
| Abstract: | Neonatal diabetes mellitus ( NDM ),which was often misdiagnosed as type 1 diabetes in the past,is a heterogenous single-gene genetic disease.Permanent neonatal diabetes( PNDM )is mainly associated with mutation in KCNJ11,ABCC8,and insulin associated gene instead of immunity.The most common manifestation includes diabetic ketoacidosis,intrauterine growth retardation and dehydration.Gene examination contributes to the classification of NDM and corresponding targeted therapy.Oral sulfonylurea may be used in treating patients with gene mutation of ATP-sensitive K+ channel. |
| |
| Keywords: | Neonatal diabetes mellitus Gene mutation Therapy |
| 本文献已被 万方数据 等数据库收录！ |
|
